What does Biohaven Ltd. do?
Biohaven Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for immunology, neuroscience, and oncology therapeutic areas worldwide. It develops BHV-1300, which is in Phase 2 clinical trial to treat Graves' disease and rheumatoid arthritis; BHV-1400 that is in…
What is Biohaven Ltd.'s P/E and P/B ratio?
Biohaven Ltd. has a P/E ratio of -3.2 and a P/B ratio of 181.54.
What is Biohaven Ltd.'s debt-to-equity ratio?
Biohaven Ltd. has a debt-to-equity ratio of 24.30.
How much does Biohaven Ltd. owe compared with what it owns?
Biohaven Ltd. owes $0.97 for every $1 it owns (balance sheet Jun 2026), which is high.
What is Biohaven Ltd.'s Positivity rank?
Biohaven Ltd. is ranked #6,728 of 6,774 companies globally and #3,958 of 4,000 in United States on PositoAI, with a Positivity Score of -94,587.
Does Biohaven Ltd. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Biohaven Ltd..
Where can I read the latest news about Biohaven Ltd.?
Recent headlines about Biohaven Ltd. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Biohaven Ltd. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Biohaven Ltd.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.